Axio BioPharma is aiming to revolutionize biopharmaceutical manufacturing through the power of artificial intelligence. By leveraging our proprietary AI model, we accelerate the development of mammalian expressed recombinant protein therapeutics, dramatically shortening the timeline from initial lab research to clinical manufacturing readiness. Our innovative approach not only increases efficiency but also significantly reduces costs, setting new standards in the biopharma industry.